Gefitinib Zentiva

Gefitinib Zentiva is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Zentiva is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced stages of NSCLC where the cancer has specific EGFR mutations.

Common effects of Gefitinib Zentiva may include skin rash, diarrhea, and appetite loss. Some users also report dry skin, nausea, and fatigue. These effects can vary in intensity and duration, depending on individual responses to the medication.

Gefitinib Zentiva should be handled with care, especially for individuals with pre-existing medical conditions such as heart or lung disease. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women and those planning to become pregnant should discuss the potential risks with their doctor.

Gefitinib Zentiva may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, consuming grapefruit or grapefruit juice while taking this medication should be avoided, as it can affect how the body processes Gefitinib.